Sökning: WFRF:(Rautiainen S.) > International compa...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05958naa a2201141 4500 | |
001 | oai:gup.ub.gu.se/320594 | |
003 | SwePub | |
008 | 240528s2022 | |||||||||||000 ||eng| | |
024 | 7 | a https://gup.ub.gu.se/publication/3205942 URI |
024 | 7 | a https://doi.org/10.1111/dme.147662 DOI |
040 | a (SwePub)gu | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Prigge, R.4 aut |
245 | 1 0 | a International comparison of glycaemic control in people with type 1 diabetes: an update and extension |
264 | c 2021-12-26 | |
264 | 1 | b Wiley,c 2022 |
520 | a Aims: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes. Methods: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 population and five clinic-based data sources in countries or regions between 2016 and 2020. Median HbA1c(IQR) and proportions of individuals with HbA1c < 58mmol/mol (<7.5%), 58–74mmol/mol (7.5–8.9%) and ≥75mmol/mol (≥9.0%) were compared between populations for individuals aged <15, 15–24 and ≥25 years. Logistic regression was used to estimate the odds ratio (OR) of HbA1c < 58mmol/mol (<7.5%) relative to ≥58mmol/mol (≥7.5%), stratified and adjusted for sex, age and data source. Where possible, changes in the proportion of individuals in each HbA1c category compared to previous estimates were calculated. Results: Median HbA1c varied from 55 to 79mmol/mol (7.2 to 9.4%) across data sources and age groups so a pooled estimate was deemed inappropriate. OR (95% CI) for HbA1c< 58mmol/mol (<7.5%) were 0.91 (0.90–0.92) for women compared to men, 1.68 (1.65–1.71) for people aged <15years and 0.81 (0.79–0.82) aged15–24years compared to those aged ≥25years. Differences between populations persisted after adjusting for sex, age and data source. In general, compared to our previous analysis, the proportion of people with an HbA1c<58mmol/l (<7.5%) increased and proportions of people with HbA1c≥ 75mmol/mol (≥9.0%) decreased. Conclusions: Glycaemic control of type 1 diabetes continues to vary substantially between age groups and data sources. While some improvement over time has been observed, glycaemic control remains sub-optimal for most people with Type 1 diabetes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
653 | a glycaemic control | |
653 | a HbA1c | |
653 | a registers of people with diabetes | |
653 | a type 1 diabetes | |
653 | a glycosylated hemoglobin | |
653 | a adult | |
653 | a child | |
653 | a cross-sectional study | |
653 | a female | |
653 | a glucose blood level | |
653 | a glycemic control | |
653 | a human | |
653 | a insulin dependent diabetes mellitus | |
653 | a male | |
653 | a Blood Glucose | |
653 | a Cross-Sectional Studies | |
653 | a Diabetes Mellitus | |
653 | a Type 1 | |
653 | a Glycated Hemoglobin A | |
653 | a Humans | |
700 | 1 | a McKnight, J. A.4 aut |
700 | 1 | a Wild, S. H.4 aut |
700 | 1 | a Haynes, A.4 aut |
700 | 1 | a Jones, T. W.4 aut |
700 | 1 | a Davis, E. A.4 aut |
700 | 1 | a Rami-Merhar, B.4 aut |
700 | 1 | a Fritsch, M.4 aut |
700 | 1 | a Prchla, C.4 aut |
700 | 1 | a Lavens, A.4 aut |
700 | 1 | a Doggen, K.4 aut |
700 | 1 | a Chao, S.4 aut |
700 | 1 | a Aronson, R.4 aut |
700 | 1 | a Brown, R.4 aut |
700 | 1 | a Ibfelt, E. H.4 aut |
700 | 1 | a Svensson, J.4 aut |
700 | 1 | a Young, R.4 aut |
700 | 1 | a Warner, J. T.4 aut |
700 | 1 | a Robinson, H.4 aut |
700 | 1 | a Laatikainen, T.4 aut |
700 | 1 | a Rautiainen, P.4 aut |
700 | 1 | a Delemer, B.4 aut |
700 | 1 | a Souchon, P. F.4 aut |
700 | 1 | a Diallo, A. M.4 aut |
700 | 1 | a Holl, R. W.4 aut |
700 | 1 | a Schmid, S. M.4 aut |
700 | 1 | a Raile, K.4 aut |
700 | 1 | a Tigas, S.4 aut |
700 | 1 | a Bargiota, A.4 aut |
700 | 1 | a Zografou, I.4 aut |
700 | 1 | a Luk, A. O. Y.4 aut |
700 | 1 | a Chan, J. C. N.4 aut |
700 | 1 | a Dinneen, S. F.4 aut |
700 | 1 | a Buckley, C. M.4 aut |
700 | 1 | a Kgosidialwa, O.4 aut |
700 | 1 | a Cherubini, V.4 aut |
700 | 1 | a Gesuita, R.4 aut |
700 | 1 | a Strele, I.4 aut |
700 | 1 | a Pildava, S.4 aut |
700 | 1 | a Veeze, H.4 aut |
700 | 1 | a Aanstoot, H. J.4 aut |
700 | 1 | a Mul, D.4 aut |
700 | 1 | a Jefferies, C.4 aut |
700 | 1 | a Cooper, J. G.4 aut |
700 | 1 | a Løvaas, K. F.4 aut |
700 | 1 | a Battelino, T.4 aut |
700 | 1 | a Dovc, K.4 aut |
700 | 1 | a Bratina, N.4 aut |
700 | 1 | a Eeg-Olofsson, Katarina,d 1968u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xeegka |
700 | 1 | a Svensson, Ann-Marie,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xsannh |
700 | 1 | a Gudbjörnsdottir, Soffia,d 1962u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine4 aut0 (Swepub:gu)xgudso |
700 | 1 | a Globa, E.4 aut |
700 | 1 | a Zelinska, N.4 aut |
710 | 2 | a Göteborgs universitetb Institutionen för medicin, avdelningen för molekylär och klinisk medicin4 org |
773 | 0 | t Diabetic Medicined : Wileyg 39:5q 39:5x 0742-3071x 1464-5491 |
856 | 4 8 | u https://gup.ub.gu.se/publication/320594 |
856 | 4 8 | u https://doi.org/10.1111/dme.14766 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.